Skip to main content

Post-IPO Equity Therapeutics Companies

Explore 207 therapeutics startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
207
Total Funding
$325.1M
Avg Funding
$46.4M
Cities
7

Export 207 Post-IPO Equity Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Newton, United States
$2.8M
raised

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

May 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$10.0M
raised

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Los Angeles, United States
$10.0M
raised

Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Stevenage, United Kingdom
$26.1M
raised

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Mar 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$125.0M
raised

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 207 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Saint Laurent, Canada
$101.2M
raised

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Oct 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$50.0M
raised

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Jul 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 201 to 207 of 207 companies

Ready to Connect with Post-IPO Equity Therapeutics Startups?

Get verified founder emails, funding details, and company data for 207 post-ipo equity therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked